These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 20406102)
1. Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases. Zgheib NK; Mitri Z; Geryess E; Noutsi P Genet Test Mol Biomarkers; 2010 Jun; 14(3):393-7. PubMed ID: 20406102 [TBL] [Abstract][Full Text] [Related]
2. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Ulusoy G; Arinç E; Adali O Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320 [TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population. Sangrajrang S; Jedpiyawongse A; Srivatanakul P Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334 [TBL] [Abstract][Full Text] [Related]
4. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer. Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075 [TBL] [Abstract][Full Text] [Related]
5. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304 [TBL] [Abstract][Full Text] [Related]
6. [Association analysis of gene polymorphism in alcohol metabolizing enzymes with risk for coronary atherosclerosis]. Marusin AV; Stepanov VA; Spiridonova MG; Khar'kov VA; Pel's IaR; Puzyrev VP Genetika; 2007 Mar; 43(3):409-16. PubMed ID: 17486761 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms in workers exposed to benzene]. Chen Z; Ling J; Liu Y; Wu X; Wang D; Wang J; Tu H Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Aug; 33(8):595-7. PubMed ID: 26653810 [TBL] [Abstract][Full Text] [Related]
8. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. Tang K; Li Y; Zhang Z; Gu Y; Xiong Y; Feng G; He L; Qin S BMC Cancer; 2010 Oct; 10():575. PubMed ID: 20969746 [TBL] [Abstract][Full Text] [Related]
9. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Liu S; Park JY; Schantz SP; Stern JC; Lazarus P Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women. Zgheib NK; Shamseddine AA; Geryess E; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; El-Saghir NS Mutat Res; 2013; 747-748():40-7. PubMed ID: 23628324 [TBL] [Abstract][Full Text] [Related]
11. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients. Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018 [TBL] [Abstract][Full Text] [Related]
12. The frequency of cytochrome P450 2E1 polymorphisms in Black South Africans. Chelule PK; Pegoraro RJ; Gqaleni N; Dutton MF Dis Markers; 2006; 22(5-6):351-4. PubMed ID: 17264406 [TBL] [Abstract][Full Text] [Related]
13. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. Zhou GW; Hu J; Li Q World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843 [TBL] [Abstract][Full Text] [Related]
14. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Farker K; Lehmann MH; Kästner R; Hoffmann A; Janitzky V; Schubert J; Matz U; Hofmann W Int J Clin Pharmacol Ther; 1998 Sep; 36(9):463-8. PubMed ID: 9760005 [TBL] [Abstract][Full Text] [Related]
15. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693 [TBL] [Abstract][Full Text] [Related]
16. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis. Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721 [TBL] [Abstract][Full Text] [Related]
17. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations. Goh LP; Chong ET; Chua KH; Chuah JA; Lee PC Asian Pac J Cancer Prev; 2014; 15(17):7377-81. PubMed ID: 25227845 [TBL] [Abstract][Full Text] [Related]
18. Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population. Gulati S; Yadav A; Kumar N; Kanupriya ; Kumar G; Aggarwal N; Gupta R Environ Toxicol Pharmacol; 2014 May; 37(3):1186-93. PubMed ID: 24814262 [TBL] [Abstract][Full Text] [Related]
19. Significance of genetic polymorphisms at multiple loci of CYP2E1 in the risk of development of childhood acute lymphoblastic leukemia. Ulusoy G; Adali O; Tumer TB; Sahin G; Gozdasoglu S; Arinç E Oncology; 2007; 72(1-2):125-31. PubMed ID: 18025800 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population. Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]